Loading…
The evolution of cognitive-behavioral therapy for psychosis
Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefit...
Saved in:
Published in: | Psychology research and behavior management 2015-01, Vol.8 (default), p.63-69 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3 |
---|---|
cites | |
container_end_page | 69 |
container_issue | default |
container_start_page | 63 |
container_title | Psychology research and behavior management |
container_volume | 8 |
creator | Mander, Helen Kingdon, David |
description | Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis. |
doi_str_mv | 10.2147/PRBM.S52267 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A447881995</galeid><doaj_id>oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95</doaj_id><sourcerecordid>A447881995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</originalsourceid><addsrcrecordid>eNptkl2L1DAUhoso7jLulfdSEESQjvlsGgRhXfxYWFF0vQ5pejLN0DbdpB2Yf2-7M7POLCYXCSfPeXPO4U2SlxgtCWbi_c9fn74vf3NCcvEkOcdYyAxzUTw9up8lFzGu0bwEYoQ-T84IF5RKKs6TD7c1pLDxzTg436XepsavOje4DWQl1HrjfNBNOtQQdL9NrQ9pH7em9tHFF8kzq5sIF_tzkfz58vn26lt28-Pr9dXlTWa4EEOmc2DaFswyYATzSmNijbGUa6StqRiXJZRggUmWc4o08KosSyaw5VhLaegiud7pVl6vVR9cq8NWee3UfcCHldJhcKYBZee_pNW0JBWzpSxRZWlldEUExiD5pPVxp9WPZQuVgW6Y-jsRPX3pXK1WfqMYZWiub5GgQzEb6APE-KiiQ9T4VhHEKZ1S3u7_DP5uhDio1kUDTaM78GNUOM9Rzjkr8gl9_Qhd-zF003QVIUQyRAQR_6iVnnp2nfVTqWYWVZeMiaLA8r7V5X-oaVfQOuM7sG6KnyS8OUqoQTdDHffOiKfgux1ogo8xgH0YAUZqtqWabal2tpzoV8cjf2APJqR_AVVc3fA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229402727</pqid></control><display><type>article</type><title>The evolution of cognitive-behavioral therapy for psychosis</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Taylor & Francis (Open access)</source><creator>Mander, Helen ; Kingdon, David</creator><creatorcontrib>Mander, Helen ; Kingdon, David</creatorcontrib><description>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</description><identifier>ISSN: 1179-1578</identifier><identifier>EISSN: 1179-1578</identifier><identifier>DOI: 10.2147/PRBM.S52267</identifier><identifier>PMID: 25733937</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>20th century ; Analysis ; Behavior modification ; Behavioral medicine ; Care and treatment ; Cognition & reasoning ; Cognitive therapy ; Complications and side effects ; Dementia ; Hallucinations ; Health aspects ; history ; Mental disorders ; Mental health care ; Physical restraints ; Psychiatry ; Psychosis ; Psychotherapy ; Psychotic disorders ; Psychotropic drugs ; Review ; Schizophrenia ; Systematic review</subject><ispartof>Psychology research and behavior management, 2015-01, Vol.8 (default), p.63-69</ispartof><rights>COPYRIGHT 2015 Dove Medical Press Limited</rights><rights>2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Mander and Kingdon. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2229402727/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2229402727?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,25753,27922,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25733937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mander, Helen</creatorcontrib><creatorcontrib>Kingdon, David</creatorcontrib><title>The evolution of cognitive-behavioral therapy for psychosis</title><title>Psychology research and behavior management</title><addtitle>Psychol Res Behav Manag</addtitle><description>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</description><subject>20th century</subject><subject>Analysis</subject><subject>Behavior modification</subject><subject>Behavioral medicine</subject><subject>Care and treatment</subject><subject>Cognition & reasoning</subject><subject>Cognitive therapy</subject><subject>Complications and side effects</subject><subject>Dementia</subject><subject>Hallucinations</subject><subject>Health aspects</subject><subject>history</subject><subject>Mental disorders</subject><subject>Mental health care</subject><subject>Physical restraints</subject><subject>Psychiatry</subject><subject>Psychosis</subject><subject>Psychotherapy</subject><subject>Psychotic disorders</subject><subject>Psychotropic drugs</subject><subject>Review</subject><subject>Schizophrenia</subject><subject>Systematic review</subject><issn>1179-1578</issn><issn>1179-1578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl2L1DAUhoso7jLulfdSEESQjvlsGgRhXfxYWFF0vQ5pejLN0DbdpB2Yf2-7M7POLCYXCSfPeXPO4U2SlxgtCWbi_c9fn74vf3NCcvEkOcdYyAxzUTw9up8lFzGu0bwEYoQ-T84IF5RKKs6TD7c1pLDxzTg436XepsavOje4DWQl1HrjfNBNOtQQdL9NrQ9pH7em9tHFF8kzq5sIF_tzkfz58vn26lt28-Pr9dXlTWa4EEOmc2DaFswyYATzSmNijbGUa6StqRiXJZRggUmWc4o08KosSyaw5VhLaegiud7pVl6vVR9cq8NWee3UfcCHldJhcKYBZee_pNW0JBWzpSxRZWlldEUExiD5pPVxp9WPZQuVgW6Y-jsRPX3pXK1WfqMYZWiub5GgQzEb6APE-KiiQ9T4VhHEKZ1S3u7_DP5uhDio1kUDTaM78GNUOM9Rzjkr8gl9_Qhd-zF003QVIUQyRAQR_6iVnnp2nfVTqWYWVZeMiaLA8r7V5X-oaVfQOuM7sG6KnyS8OUqoQTdDHffOiKfgux1ogo8xgH0YAUZqtqWabal2tpzoV8cjf2APJqR_AVVc3fA</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Mander, Helen</creator><creator>Kingdon, David</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove Press</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150101</creationdate><title>The evolution of cognitive-behavioral therapy for psychosis</title><author>Mander, Helen ; Kingdon, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>20th century</topic><topic>Analysis</topic><topic>Behavior modification</topic><topic>Behavioral medicine</topic><topic>Care and treatment</topic><topic>Cognition & reasoning</topic><topic>Cognitive therapy</topic><topic>Complications and side effects</topic><topic>Dementia</topic><topic>Hallucinations</topic><topic>Health aspects</topic><topic>history</topic><topic>Mental disorders</topic><topic>Mental health care</topic><topic>Physical restraints</topic><topic>Psychiatry</topic><topic>Psychosis</topic><topic>Psychotherapy</topic><topic>Psychotic disorders</topic><topic>Psychotropic drugs</topic><topic>Review</topic><topic>Schizophrenia</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mander, Helen</creatorcontrib><creatorcontrib>Kingdon, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Psychology research and behavior management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mander, Helen</au><au>Kingdon, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evolution of cognitive-behavioral therapy for psychosis</atitle><jtitle>Psychology research and behavior management</jtitle><addtitle>Psychol Res Behav Manag</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>8</volume><issue>default</issue><spage>63</spage><epage>69</epage><pages>63-69</pages><issn>1179-1578</issn><eissn>1179-1578</eissn><abstract>Cognitive therapy for psychosis has developed over the past 30 years from initial case studies, treatment manuals, pilot randomized controlled studies to fully powered and methodologically rigorous efficacy and, subsequently, effectiveness trials. Reviews and meta-analyses have confirmed the benefits of the interventions. Considered appraisal by government and professional organizations has now led to its inclusion in international treatment guidelines for schizophrenia. Patients consistently ask for access to psychotherapeutic interventions, and it is slowly becoming available in many European countries and other parts of the world, eg, US and the People's Republic of China. However, it remains unacceptably difficult to access for the vast majority of people with psychosis who could benefit from it. Psychosis affects people in the prime of their lives and leads to major effects on their levels of distress, well-being, and functioning, and also results in major costs to society. Providing effective interventions at an early stage has the potential to reduce the high relapse rates that occur after recovery from first episode and the ensuing morbidity and premature mortality associated with psychosis.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>25733937</pmid><doi>10.2147/PRBM.S52267</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1179-1578 |
ispartof | Psychology research and behavior management, 2015-01, Vol.8 (default), p.63-69 |
issn | 1179-1578 1179-1578 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_f6e4a9fa3b2d4fb9b0df3dcad2711e95 |
source | PubMed (Medline); Publicly Available Content Database; Taylor & Francis (Open access) |
subjects | 20th century Analysis Behavior modification Behavioral medicine Care and treatment Cognition & reasoning Cognitive therapy Complications and side effects Dementia Hallucinations Health aspects history Mental disorders Mental health care Physical restraints Psychiatry Psychosis Psychotherapy Psychotic disorders Psychotropic drugs Review Schizophrenia Systematic review |
title | The evolution of cognitive-behavioral therapy for psychosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evolution%20of%20cognitive-behavioral%20therapy%20for%20psychosis&rft.jtitle=Psychology%20research%20and%20behavior%20management&rft.au=Mander,%20Helen&rft.date=2015-01-01&rft.volume=8&rft.issue=default&rft.spage=63&rft.epage=69&rft.pages=63-69&rft.issn=1179-1578&rft.eissn=1179-1578&rft_id=info:doi/10.2147/PRBM.S52267&rft_dat=%3Cgale_doaj_%3EA447881995%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c577t-a6e4af84f4e4215da12fccf35a0afcd459bebefe4946530ae5dbbb471f51a99c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229402727&rft_id=info:pmid/25733937&rft_galeid=A447881995&rfr_iscdi=true |